Follow
David W Mullins
David W Mullins
Associate Professor and Associate Dean, Geisel School of Medicine, Dartmouth College
Verified email at dartmouth.edu - Homepage
Title
Cited by
Cited by
Year
Tumor‐induced immune dysfunction: the macrophage connection
KD Elgert, DG Alleva, DW Mullins
Journal of leukocyte biology 64 (3), 275-290, 1998
5801998
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional …
DW Mullins, SL Sheasley, RM Ream, TNJ Bullock, YX Fu, VH Engelhard
The Journal of experimental medicine 198 (7), 1023-1034, 2003
2802003
Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy
TA Colella, TNJ Bullock, LB Russell, DW Mullins, WW Overwijk, ...
The Journal of experimental medicine 191 (7), 1221-1232, 2000
2052000
Antigens derived from melanocyte differentiation proteins: Self‐tolerance, autoimmunity, and use for cancer immunotherapy
VH Engelhard, TNJ Bullock, TA Colella, SL Sheasley, DW Mullins
Immunological reviews 188 (1), 136-146, 2002
1642002
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease
IM Mullins, CL Slingluff, JK Lee, CF Garbee, J Shu, SG Anderson, ...
Cancer research 64 (21), 7697-7701, 2004
1632004
Systematic pan-cancer analysis reveals immune cell interactions in the tumor microenvironment
FS Varn, Y Wang, DW Mullins, S Fiering, C Cheng
Cancer research 77 (6), 1271-1282, 2017
1502017
Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells
TNJ Bullock, DW Mullins, VH Engelhard
The Journal of Immunology 170 (4), 1822-1829, 2003
1412003
Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide
DW Mullins, CJ Burger, KD Elgert
The Journal of Immunology 162 (11), 6811-6818, 1999
1411999
Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge
JR Baird, KT Byrne, PH Lizotte, S Toraya-Brown, UK Scarlett, ...
The Journal of Immunology 190 (1), 469-478, 2013
1162013
Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway
RS Tacke, A Tosello-Trampont, V Nguyen, DW Mullins, YS Hahn
Journal of Biological Chemistry 286 (12), 10847-10855, 2011
1102011
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma
GV Yamshchikov, DW Mullins, CC Chang, T Ogino, L Thompson, ...
The Journal of Immunology 174 (11), 6863-6871, 2005
1002005
Manipulation of avidity to improve effectiveness of adoptively transferred CD8+ T cells for melanoma immunotherapy in human MHC class I-transgenic mice
TNJ Bullock, DW Mullins, TA Colella, VH Engelhard
The Journal of Immunology 167 (10), 5824-5831, 2001
962001
Multiple murine BRafV600E melanoma cell lines with sensitivity to PLX4032
MH Jenkins, SM Steinberg, MP Alexander, JL Fisher, MS Ernstoff, MJ Turk, ...
Pigment cell & melanoma research 27 (3), 495, 2014
942014
Immunity to melanoma antigens: from self‐tolerance to immunotherapy
CL Slingluff Jr, KA Chianese‐Bullock, TNJ Bullock, WW Grosh, ...
Advances in immunology 90, 243-295, 2006
742006
Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma
LT Dengel, AG Norrod, BL Gregory, E Clancy-Thompson, MD Burdick, ...
Journal of immunotherapy 33 (9), 965-974, 2010
712010
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel β2-microglobulin loss-of-function in melanoma cells
CC Chang, T Ogino, DW Mullins, JL Oliver, GV Yamshchikov, N Bandoh, ...
Journal of Biological Chemistry 281 (27), 18763-18773, 2006
682006
BRAF inhibition alleviates immune suppression in murine autochthonous melanoma
SM Steinberg, P Zhang, BT Malik, A Boni, TB Shabaneh, KT Byrne, ...
Cancer immunology research 2 (11), 1044-1050, 2014
652014
Adaptive immunity programmes in breast cancer
FS Varn, DW Mullins, H Arias‐Pulido, S Fiering, C Cheng
Immunology 150 (1), 25-34, 2017
632017
Immune responses to the HLA-A* 0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A* 0201-transgenic mice
DW Mullins, TNJ Bullock, TA Colella, VV Robila, VH Engelhard
The Journal of Immunology 167 (9), 4853-4860, 2001
632001
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses
JA Lo, M Kawakubo, VR Juneja, MY Su, TH Erlich, MW LaFleur, ...
Science translational medicine 13 (581), eabd8636, 2021
592021
The system can't perform the operation now. Try again later.
Articles 1–20